215 related articles for article (PubMed ID: 33370282)
1. Efficacy of aspirin, clopidogrel, and ticlopidine in stroke prevention: A population-based case-cohort study in Taiwan.
Wong YS; Tsai CF; Hsu YH; Ong CT
PLoS One; 2020; 15(12):e0242466. PubMed ID: 33370282
[TBL] [Abstract][Full Text] [Related]
2. Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real-World Data.
Chi NF; Wen CP; Liu CH; Li JY; Jeng JS; Chen CH; Lien LM; Lin CH; Sun Y; Chang WL; Hu CJ; Hsu CY;
J Am Heart Assoc; 2018 Oct; 7(19):e009856. PubMed ID: 30371321
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet Strategies and Outcomes in Patients with Noncardioembolic Ischemic Stroke from a Real-World Study with a Five-Year Follow-Up.
Xu H; Ping Y; Lin H; He P; Li W; Dai H
Transl Stroke Res; 2017 Jun; 8(3):228-233. PubMed ID: 28039577
[TBL] [Abstract][Full Text] [Related]
4. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
5. Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study.
Lee M; Wu YL; Saver JL; Lee HC; Lee JD; Chang KC; Wu CY; Lee TH; Wang HH; Rao NM; Ovbiagele B
BMJ Open; 2014 Dec; 4(12):e006672. PubMed ID: 25468508
[TBL] [Abstract][Full Text] [Related]
6. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
Jamieson DG; Parekh A; Ezekowitz MD
J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.
Zusman RM; Chesebro JH; Comerota A; Hartmann JR; Massin EK; Raps E; Wolf PA
Clin Cardiol; 1999 Sep; 22(9):559-73. PubMed ID: 10486695
[TBL] [Abstract][Full Text] [Related]
8. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone.
Hong KS; Lee SH; Kim EG; Cho KH; Chang DI; Rha JH; Bae HJ; Lee KB; Kim DE; Park JM; Kim HY; Cha JK; Yu KH; Lee YS; Lee SJ; Choi JC; Cho YJ; Kwon SU; Kim GM; Sohn SI; Park KY; Kang DW; Sohn CH; Lee J; Yoon BW;
Stroke; 2016 Sep; 47(9):2323-30. PubMed ID: 27418597
[TBL] [Abstract][Full Text] [Related]
9. Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
Milionis H; Ntaios G; Papavasileiou V; Spengos K; Manios E; Elisaf M; Vemmos K
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2769-2777. PubMed ID: 28756905
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and clopidogrel for prevention of ischemic stroke.
Thomson RM; Anderson DC
Curr Neurol Neurosci Rep; 2013 Feb; 13(2):327. PubMed ID: 23299823
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet agents for the secondary prevention of ischaemic stroke in patients with or without renal dysfunction.
Wang IK; Yen TH; Guo YC; Sun Y; Lien LM; Chang WL; Chen PL; Yang YC; Sung FC; Hsu CY
Eur J Neurol; 2020 Mar; 27(3):572-578. PubMed ID: 31693249
[TBL] [Abstract][Full Text] [Related]
12. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
Pongrácz E
Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
[TBL] [Abstract][Full Text] [Related]
13. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
[TBL] [Abstract][Full Text] [Related]
14. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials.
Hankey GJ; Sudlow CL; Dunbabin DW
Stroke; 2000 Jul; 31(7):1779-84. PubMed ID: 10884487
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke.
Sternberg Z; Chichelli T; Sternberg D; Sawyer R; Ching M; Janicke D; Ambrus JL; Yu J; Munschauer F
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):327-34. PubMed ID: 26586373
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
[TBL] [Abstract][Full Text] [Related]
17. Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.
Grau AJ; Reiners S; Lichy C; Buggle F; Ruf A
Stroke; 2003 Apr; 34(4):849-54. PubMed ID: 12637702
[TBL] [Abstract][Full Text] [Related]
18. Switching from aspirin to clopidogrel in patients with aspirin resistance after an ischemic stroke. Is it a good solution?
Castilla-Guerra L; Fernandez-Moreno Mdel C; Navas-Alcantara MS; Jimenez-Gonzalo F
Eur J Intern Med; 2014 Mar; 25(3):e40-1. PubMed ID: 24484620
[No Abstract] [Full Text] [Related]
19. Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin.
Kim JT; Kim BJ; Park JM; Lee SJ; Cha JK; Park TH; Lee KB; Lee J; Hong KS; Lee BC; Kim DE; Choi JC; Kwon JH; Shin DI; Sohn SI; Lee JS; Lee J; Bae HJ
Sci Rep; 2020 Oct; 10(1):16723. PubMed ID: 33028887
[TBL] [Abstract][Full Text] [Related]
20. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
Davis KA; Miyares MA; Dietrich E
Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
